Cullinan Therapeutics, Inc. (CGEM)
NASDAQ · Healthcare
Cullinan Therapeutics, Inc. annual/quarterly shareholder equity history from 2020 to 2022. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Cullinan Therapeutics, Inc. shareholder equity for the quarter ending December 31, 2022 were 535.0M, a 25.90% increase year-over-year.
- Cullinan Therapeutics, Inc. shareholder equity for 2022 were 535.0M, a 25.90% increase from 2021.
- Cullinan Therapeutics, Inc. shareholder equity for 2021 were 425.0M, a 113.54% increase from 2020.
- Cullinan Therapeutics, Inc. shareholder equity for 2020 were 199.0M.
Shareholder Equity
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Cullinan Therapeutics, Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2022 | $535 |
| 2021 | $425 |
| 2020 | $199 |
| Cullinan Therapeutics, Inc. Quarterly Shareholder Equity (Millions of US $) | |
|---|---|
| 2022-12-31 | $535 |
| 2021-12-31 | $425 |
| 2020-12-31 | $199 |
Cullinan Therapeutics, Inc. Shareholder Equity — FAQ
Cullinan Therapeutics, Inc. (CGEM) shareholder equity over the last 3 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see CGEM's shareholder equity history?
The chart and table above show Cullinan Therapeutics, Inc.'s shareholder equity by year and by quarter, including the growth rate.